US-based healthcare company electroCore has raised $40m from Merck's Global Healthcare Innovation Fund. Other participants in the round of financing are private equity groups including Easton Capital and Core Ventures. The company will ...
Tags: Electrocore, Therapy Device, Medicine
Therapeutic Goods Administration in Australia and the National Institute of Surveillance of Medicine and Foods in the Ministry of Health in Colombia have approved ElectroCore's non-invasive, non-pharmaceutical vagus nerve stimulation ...
Tags: ElectroCore, Therapeutic Goods, Medicine
ElectroCore has initiated enrolling patients in a clinical trial of its GammaCore nVNS therapy, designed for preventing chronic migraine. The easy-to-use, non-invasive device, which enables self-administration of therapy, stimulates ...